Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| INVITROGEN CORP | 24,394 | reported | 01 Apr 2011 | tx 147+542,149.38−383,553 |
| Twist Bioscience Corp | 23,021 | reported | 21 Nov 2022 | tx 14+85,873−19,082 |
| REPLIGEN CORP | 5,436 | reported | 14 May 2026 | tx 50+102,195−79,420 |
| 908 Devices Inc. | 0 | reported | 15 Jun 2022 | tx 15+60,164−40,920 |
| STANDARD BIOTOOLS INC. | 0 | reported | 01 Apr 2022 | tx 40+306,091−58,316 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 May 2026 | GRANT_AWARD | REPLIGEN CORP | 995 | 0.00 USD | |
| 14 May 2026 | GRANT_AWARD | REPLIGEN CORP | 2,239 | 0.00 USD | deriv |
| 15 May 2025 | GRANT_AWARD | REPLIGEN CORP | 973 | 0.00 USD | |
| 15 May 2025 | GRANT_AWARD | REPLIGEN CORP | 1,800 | 0.00 USD | deriv |
| 14 Jun 2024 | PURCHASE | REPLIGEN CORP | 1,200 | 125.45 USD | first after silence |
| 16 May 2024 | GRANT_AWARD | REPLIGEN CORP | 701 | 0.00 USD | |
| 16 May 2024 | GRANT_AWARD | REPLIGEN CORP | 1,376 | 0.00 USD | deriv |
| 18 May 2023 | GRANT_AWARD | REPLIGEN CORP | 686 | 0.00 USD | |
| 18 May 2023 | GRANT_AWARD | REPLIGEN CORP | 1,487 | 0.00 USD | deriv |
| 21 Nov 2022 | EXERCISE | Twist Bioscience Corp | 9,082 | 23.33 USD | |
| 21 Nov 2022 | EXERCISE | Twist Bioscience Corp | 9,082 | 0.00 USD | deriv |
| 15 Jun 2022 | EXERCISE | 908 Devices Inc. | 1,379 | — | |
| 15 Jun 2022 | EXERCISE | 908 Devices Inc. | 1,379 | 0.00 USD | deriv |
| 26 May 2022 | GRANT_AWARD | REPLIGEN CORP | 534 | 0.00 USD | |
| 26 May 2022 | GRANT_AWARD | REPLIGEN CORP | 1,298 | 0.00 USD | deriv |
| 11 May 2022 | PURCHASE | Twist Bioscience Corp | 8,550 | 29.25 USD | first after silence |
| 01 Apr 2022 | EXERCISE | STANDARD BIOTOOLS INC. | 20,993 | 3.74 USD | |
| 01 Apr 2022 | EXERCISE | STANDARD BIOTOOLS INC. | 20,993 | 3.74 USD | deriv |
| 31 Mar 2022 | EXERCISE | STANDARD BIOTOOLS INC. | 5,000 | 3.43 USD | |
| 31 Mar 2022 | EXERCISE | STANDARD BIOTOOLS INC. | 5,000 | 3.43 USD | deriv |
| 08 Feb 2022 | GRANT_AWARD | Twist Bioscience Corp | 3,491 | 0.00 USD | |
| 29 Oct 2021 | SALE | REPLIGEN CORP | 360 | 288.19 USD | |
| 29 Oct 2021 | SALE | REPLIGEN CORP | 1,285 | 288.20 USD | |
| 29 Oct 2021 | EXERCISE | REPLIGEN CORP | 1,285 | 128.18 USD | |
| 29 Oct 2021 | EXERCISE | REPLIGEN CORP | 1,285 | 0.00 USD | deriv |
4 purchases reported after at least 12 months of silence — most recent on 14 Jun 2024.